Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Quinn

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Reviews in Urology|September 21, 2006
The future in advanced prostate cancer: take your partners or is the last dance for me?David I Quinn
Clinical Nuclear Medicine|November 12, 2013
Targeted α-particle therapy of bone metastases in prostate cancerHossein Jadvar, David I Quinn
Cancer|August 1, 2009
Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?Tanya B Dorff, David I Quinn
The New England Journal of Medicine|September 26, 2015
Renal-Cell Cancer--Targeting an Immune Checkpoint or Multiple KinasesDavid I Quinn, Primo N Lara
Cancer Treatment Reviews|February 26, 2013
Differentiating mTOR inhibitors in renal cell carcinomaSumanta K Pal, David I Quinn
Clinical Genitourinary Cancer|January 24, 2006
Cytokine therapy: a standard of care for metastatic renal cell carcinoma?Thomas E Hutson, David I Quinn
Lancet (London, England)|October 5, 2010
Cabazitaxel in prostate cancer: stretching a stringTanya B Dorff, David I Quinn
The Journal of Urology|October 30, 2019
Editorial CommentAnishka A D'Souza, David I Quinn
Clinical Prostate Cancer|January 8, 2005
Angiogenesis-targeted therapies in prostate cancerPrimo N Lara, Przemyslaw Twardowski, David I Quinn
Urologic Oncology|June 22, 2015
Relapsed and refractory germ cell tumors: Finessing the rough end of a beautiful storyTanya B Dorff, James Hu, David I Quinn
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Reviews in Urology|September 21, 2006
The future in advanced prostate cancer: take your partners or is the last dance for me?David I Quinn
Clinical Nuclear Medicine|November 12, 2013
Targeted α-particle therapy of bone metastases in prostate cancerHossein Jadvar, David I Quinn
Cancer|August 1, 2009
Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?Tanya B Dorff, David I Quinn
The New England Journal of Medicine|September 26, 2015
Renal-Cell Cancer--Targeting an Immune Checkpoint or Multiple KinasesDavid I Quinn, Primo N Lara
Cancer Treatment Reviews|February 26, 2013
Differentiating mTOR inhibitors in renal cell carcinomaSumanta K Pal, David I Quinn
Clinical Genitourinary Cancer|January 24, 2006
Cytokine therapy: a standard of care for metastatic renal cell carcinoma?Thomas E Hutson, David I Quinn
Lancet (London, England)|October 5, 2010
Cabazitaxel in prostate cancer: stretching a stringTanya B Dorff, David I Quinn
The Journal of Urology|October 30, 2019
Editorial CommentAnishka A D'Souza, David I Quinn
Clinical Prostate Cancer|January 8, 2005
Angiogenesis-targeted therapies in prostate cancerPrimo N Lara, Przemyslaw Twardowski, David I Quinn
Urologic Oncology|June 22, 2015
Relapsed and refractory germ cell tumors: Finessing the rough end of a beautiful storyTanya B Dorff, James Hu, David I Quinn
Pageof 21